Biochip Products and Services Market was valued at USD 2.4 billion in 2011 and
is expected to grow at a CAGR of 10.1% from 2013 to 2019, to reach an estimated
value of USD 4.7 billion in 2019.
The most important growth driver of this market is
the increasing application of genomics and proteomics in cancer treatment
research, leading to an increase in the use of microarrays and reagents.
Furthermore, growth in drug discovery, personalized medicine and life science
research, along with developments such as the U.S. FDA approval of personalized
medicines for treatment of melanoma and lung cancer will also support future
growth of this market.
Microarrays held the majority share of the total
market in 2011, on account of technological advancements in the field of
microarrays and increased commercial application of biochips post the success
of the Human Genome Project (HGP). Within this segment, the highest market
share is held by DNA chips, due to increasing gene expression profiling in drug
delivery and epidemiological research. The laboratory and protein chip segments
are expected to experience maximum growth within the microarrays segment, due
to product advancements and broadening capabilities in drug delivery and
diagnostic testing. The market for reagents and other consumables holds the
potential for highest growth; it is expected to grow at a CAGR of 10.7% from 2013
to 2019, due to the need for higher quality of sample preparation, and labeling
and purification agents.
Drug delivery held the highest market share by
application in 2011, at over 50%, on account of the increased use of biochip
technology in gene expression analysis, single nucleotide polymorphism (SNP)
identification and genotyping, protein analysis and characterization in drug
delivery. The market for other applications including disease management,
forensic medicine, military and defense applications, and agriculture, will
witness the highest growth rate during the forecast period.
The key market players in the U.S. biochip market
are Affymetrix, Inc., Life Technologies Corporation and Illumina, Inc. Other
important market players include Becton, Dickinson and Company and Agilent
Technologies. The market witnesses low product differentiation, and increasing
strategic alliances and collaborative developments.
The U.S. biochip market is categorized into the
following segments:
§ Biochip Market, by Segments
o Biochip
Products Market
o Biochip
Services Market
§ Biochip Products Market, by Types
o Microarrays
o Reagents
and Other Consumables
o Others
(Biochip Instruments and Software)
§ Biochip Products and Services
Market, by Applications
o Drug
Delivery
o Life
Science Research
o In Vitro
Diagnostic Testing
o Others
(Disease Management, Forensic Medicine, Defense)
Browse the full report at http://www.transparencymarketresearch.com/biochip-products-services.html
About
UsTransparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Visit: http://de.transparencymarketresearch.com/
Visit: http://www.europlat.org/
No comments:
Post a Comment